EAS Newsletter March 4, 2025
Outreach:
AtheroTalk: Inside Dr Mate Kiss’s award-winning atherosclerosis research
This episode is a special one! We sit down for an inspiring conversation with Dr Mate Kiss, winner of the Young Investigator Award in Basic Science for 2023, as he guides us through his groundbreaking research on Cell-autonomous regulation of complement C3 by factor H limits macrophage efferocytosis and exacerbates atherosclerosis, published in Immunity (http://doi.org/10.1016/j.immuni.2023.06.026).
Dr Kiss shares his journey as an early-career scientist, key insights from his award-winning work, and the challenges he overcame along the way. We also delve into his latest research on the intriguing connection between sleep and atherosclerosis.
————————————————-
Script-prep: Fotios Barkas, Mariia Cherska, Azin Kheirkhah, Sanne Maas, Emiel van der Vorst
Interviewer: Florentina Porsch
Education:
Featured Open Lecture: TG-rich lipoproteins: stars or second advantage in the field of residual CV risk? by Prof. Alberto Zambon
This presentation was given by Professor Alberto Zambon as part of the EAS-LatAm webinar entitled ‘Triglyceride-rich lipoproteins as contributors to residual risk.’ Professor Zambon is a world-renowned professor at the University of Padova, Italy, a former member of the EAS Executive Committee, and a current member of the EAS National Societies Committee.
In his excellent and up-to-date overview, Professor Zambon emphasized that findings from genetic studies, clinical trials, and epidemiology strongly support the causal association of triglyceride-rich lipoprotein levels (both fasting and postprandial) with atherogenesis.
He then presented the recommendations for drug treatment of patients with hypertriglyceridemia from the 2021 ESC Guidelines for cardiovascular disease prevention in clinical practice, and discussed the effectiveness of fibrates and omega-3 fatty acids.
Additionally, he presented the suggested algorithm for the treatment of high- and very high-risk patients with elevated triglycerides, which was recently published in ‘Atherosclerosis.’ This is a very comprehensive lecture you should not miss.
To the Open Lecture by Prof. Alberto ZambonEducation:
Register for our first EAS webinar in 2025!
This webinar is fast approaching! Get the latest insights on androgen therapies and cardiovascular health. Our expert speakers will present valuable evidence on androgen-related cardiovascular risks and benefits, offering essential guidance for healthcare professionals.
Explore our speakers and register now to secure your spot!
To the registration pageCongress:
This is the last chance to submit your late-breaking abstract for the EAS Congress 2025
Got groundbreaking research that deserves the spotlight? This is your chance to present new, unpublished results that weren’t available by the regular abstract deadline. Submit your late-breaking abstract for EAS Congress 2025 before the March 11 deadline and make your work shine!
Submit your abstract nowSociety:
EAS Calendar – February-March 2025
From insightful webinars to groundbreaking announcements, this section is your gateway to staying connected and up-to-date with the latest developments within the EAS Society.
February 18 – March 11, Late breaking abstract submission: EAS Congress 2025
March 19-21, 2nd Postgraduate Course in Cardiometabolic Medicine
March 20, EAS webinar: Cardiovascular challenges in androgen therapies: From androgen deficiency to gender dysphoria
March 21, Joint session at Colombian Congress of Cardiology & Cardiovascular Surgery